Drug
Tick Borne Encephalitis Vaccine
Tick Borne Encephalitis Vaccine: highest development phase Post-Market, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tick-Borne Encephalitis vaccine NCT00311441 | Post-Market | Encephalitis, Tick-Borne |
Latest
No recent events.
Follow Tick Borne Encephalitis Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.